Few burning questions from my end, really appreciate it you are able to ask a few of them. 2 and 5 are the most important.
1. Do we still have a partnership with DXB, their Ph2 trail has concluded and PromarkerD was never mentioned. 2. Part of the $3 placement in November 2019 was to secure the reimbursement code (CPT) for the US, given we are now 12months past and still have not received the CPT code, do you have a timeline on when you expect to receive it? 4. What is the timeline for US regulatory approval? 5. Is the validation study for Giardia still on track to be completed this calendar year? 6. Are we still in partnership with Atturos and has there been any progress with their prostrate cancer test (OCProDx)? 7. Is Omics GlobalSolutions still marketing the test in the Dominican Republic?
Cheers Eqz
PIQ Price at posting:
51.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)